You are here: Home > Institute of Excellence (CPD) > CPD Events > WAVE24 On Demand: Atropine for Myopia Control – Samantha Lee

WAVE24 On Demand: Atropine for Myopia Control - Samantha Lee

Available from: 3/04/2024 (AEDT)

Access Here: https://wave.arinex.one/talks/day-2-6-atropine-for-myopia-control-in-the-australian-context-when-to-use-it-at-what-concentration-tx-mcqs

Provider: Optometry WA

Contact: OWA Office, [E] admin@optometrywa.org.au, [P] (08) 9321 2300

Activity Outline

Samantha Lee presents on Atropine for Myopia Control in the Australian Context – What Concentration & For How Long?

Duration: 30 minutes

Synopsis: The debate over what is the optimal atropine concentration continues. Studies in East Asia, Australia, and other parts of the world have suggested that there is no one-concentration-fits-all approach. With the known rebound effects after stopping treatment, when is a safe time to cease therapy?

Learning Objectives

  • Identify factors to consider when deciding the concentration of atropine to use
  • How to decide on when to cease 0.01% atropine therapy for myopia control

Max CPD hours awarded: 0.75

Session Information

Name
Atropine for Myopia Control in the Australian Context – What Concentration & For How Long?
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.75

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.